(Press-News.org) Scientists have long suspected the keto diet might be able to calm an overactive immune system and help some people with diseases like multiple sclerosis.
Now, they have reason to believe it could be true.
Scientists at UC San Francisco have discovered that the diet makes the gut and its microbes produce two factors that attenuated symptoms of MS in mice.
If the study translates to humans, it points toward a new way of treating MS and other autoimmune disorders with supplements.
The keto diet severely restricts carbohydrate-rich foods like bread, pasta, fruit and sugar, but allows unlimited fat consumption.
Without carbohydrates to use as fuel, the body breaks down fat instead, producing compounds called ketone bodies. Ketone bodies provide energy for cells to burn and can also change the immune system.
Working with a mouse model of MS, the researchers found that mice who produced more of a particular ketone body, called β-hydroxybutyrate (βHB), had less severe disease.
The additional βHB also prompted the gut bacterium Lactobacillus murinus to produce a metabolite called indole lactic acid (ILA). This blocked the activation of T helper 17 immune cells, which are involved in MS and other autoimmune disorders.
“What was really exciting was finding that we could protect these mice from inflammatory disease just by putting them on a diet that we supplemented with these compounds,” said Peter Turnbaugh, PhD, of the Benioff Center for Microbiome Medicine.
Earlier, Turnbaugh had shown that when secreted by the gut, βHB counteracts immune activation. This prompted a postdoctoral scholar who was then working in his lab, Margaret Alexander, PhD, to see if the compound could ease the symptoms of MS in mice.
In the new study, which appears Nov. 4 in Cell Reports, the team looked at how the ketone body-rich diet affected mice that were unable to produce βHB in their intestines, and found that their inflammation was more severe.
But when the researchers supplemented their diets with βHB, the mice got better.
To find out how βHB affects the gut microbiome, the team isolated bacteria from the guts of three groups of mice that were fed either the keto diet, a high-fat diet, or the βHB supplemented high-fat diet.
Then, they screened the metabolic products of each group’s distinct microbes in an immune assay and determined that the positive effects of the diet were coming from a member of the Lactobacillus genus: L. murinus.
Two other techniques, genome sequencing and mass spectrometry, confirmed that the L. murinus they found produced indole lactic acid, which is known to affect the immune system.
Finally, the researchers treated the MS mice with either ILA or L. murinus, and their symptoms improved.
Turnbaugh cautioned that the supplement approach still needs to be tested in people with autoimmune disorders.
“The big question now is how much of this will translate into actual patients,” he said. “But I think these results provide hope for the development of a more tolerable alternative to helping those people than asking them stick to a challenging restrictive diet.”
Authors: Additional authors of the study include Margaret Alexander, Vaibhav Upadhyay, Rachel Rock, Lorenzo Ramirez, Kai Trepka, Diego Oreilana, Qi Yan Ang, Caroline Whitty, Jessie Turnbaugh, Darren Dumlao, Renuka Nayak, and John C. Newman of UCSF, Patrycja Puchalska and Peter Crawford of the University of Minnesota, and Yuan Tian and Andrew Patterson Pennsylvania State University.
Funding: This work was funded by the NIH (grants P30 DK063720, R01DK114034, R01HL122593, R01AR074500, R01AT011117, F32AI14745601, K99AI159227, R00AI159227-03, K08HL165106, K08AR073930, R01AG067333, R01DK091538, R01AG069781) and the Damon Runyon Cancer Research Foundation (DRR4216). Turnbaugh is a Chan Zuckerberg Biohub-San Francisco Investigator.
END
How the keto diet could one day treat autoimmune disorders
A new mouse study from UCSF shows the diet increases anti-inflammatory compounds
2024-11-04
ELSE PRESS RELEASES FROM THIS DATE:
Influence of tool corner radius on chip geometrical characteristics of machining Zr-based bulk metallic glass
2024-11-04
Different from traditional alloys, BMGs exhibit a unique atomic arrangement characterized by short-range order and long-range disorder at the atomic level. Such atomic structure leads to the absence of defects such as grain boundaries and dislocations, resulting in exceptional mechanical properties. The promising properties of BMGs have rapidly positioned them as a new class of structural and functional materials, showing great application potential in various fields including structural, energy and chemical engineering. In order to facilitate their engineering applications, research has reported their cutting characteristics from various aspects, ...
Megan Huisingh-Scheetz, MD, MPH, of the University of Chicago recognized with AFAR’s Terrie Fox Wetle Rising Star Award in Health Services and Aging Research
2024-11-04
New York, NY – The American Federation for Aging Research (AFAR), is proud to recognize the outstanding contributions of Megan Huisingh-Scheetz, MD, MPH, with the 2024 Terrie Fox Wetle Rising Star Award in Health Services and AgingResearch.
This award honors a health services researcher in an early or middle phase of his/her career who has already made importantcontributions with work that respects the value of multidisciplinary health services science and that ...
Steven N. Austad, PhD, to receive inaugural George M. Martin Lifetime Achievement in Mentoring Award
2024-11-04
New York, NY–The American Federation for Aging Research (AFAR) is pleased to announce the recipient of the inaugural George M. Martin Lifetime Achievement in Mentoring Award: Steven N. Austad, PhD, Protective Life Endowed Chair in Healthy Aging Research and a Distinguished Professor in the Department of Biology at the University of Alabama at Birmingham (UAB).
The Award is named in honor of George M. Martin, MD (1927-2022), a pioneer in the field of aging research and AFAR’s Scientific Director for more than a decade. A Professor of Pathology at the University of Washington, Dr. Martin devoted his long, distinguished career to growing the field of aging ...
Jeremy D. Walston, MD, of Johns Hopkins University to receive AFAR 2024 Irving S. Wright Award of Distinction
2024-11-04
New York, NY – The American Federation for Aging Research (AFAR), is pleased to recognize the exemplary contributions of Jeremy D. Walston, MD, to the field of aging research through the 2024 Irving S. Wright Award of Distinction. This award is named in honor of AFAR’s founder and recognizes exceptional contributions to basic or clinical research in the field of aging. Established in 1982, the award is a framed citation and carries a cash prize of $5,000.
Dr. Walston, the Raymond and Anna Lublin Professor of Geriatric Medicine at Johns Hopkins University (JHU), holds multiple leadership roles at JHU, including Director of the Human Aging Project, ...
SwRI receives $23 million in U.S. Air Force contracts to sustain aging aircraft
2024-11-04
SAN ANTONIO — November 4, 2024 —Southwest Research Institute has received two contracts totaling $23 million from the U.S. Air Force for a program to address aging aircraft structures and material degradation. Under these contracts, the Institute will help the Air Force modernize methods to sustain the T-38 Talon, the A-10 Thunderbolt and the B-52 Stratofortress. All three military aircraft first came into service more than 45 years ago.
“SwRI will assist with the full spectrum of structural sustainment for these aircraft,” said Luciano Smith, manager of SwRI’s Structural Integrity Group. “Our analyses will help the Air Force know ...
Insilico Medicine enters into revolving loan facility of up to US$100 Million with HSBC
2024-11-04
Insilico Medicine(“Insilico”), a global leading generative artificial intelligence (AI)-driven biotechnology company, today announced it has signed a Revolving Loan Facility of up to US$100 million with HSBC, one of the world's largest banks and financial services institutions. HSBC’s customized financing solution will support Insilico’s global development centered on multiple sites, as well as the expansion of innovative advantages, thus driving the economy growth in the Greater Bay Area.
Insilico is committed to driving advancements in healthcare using cutting-edge AI technology, reducing costs and improving efficiency in early-stage ...
Security in quantum computing
2024-11-04
Alongside artificial intelligence, quantum computing is one of the fastest-growing subsets in the high-performance computing community. But what happens when this relatively new and powerful computing method reaches the limit of the cyberinfrastructure and network security capabilities of today?
Researchers at the National Center for Supercomputing Applications are addressing this issue before it becomes a problem.
“The problem is urgent because practical quantum computers will break classical encryption in the next decade,” ...
Noninvasive choroidal vessel analysis via deep learning: A new approach to choroidal optical coherence tomography angiography
2024-11-04
Researchers from Peking University have developed a novel noninvasive choroidal angiography method that enables layer-wise visualization and evaluation of choroidal vessels using deep learning. This new approach, published in Health Data Science, employs an advanced segmentation model that can handle varying quality of optical coherence tomography (OCT) B-scans, making it a promising tool for clinical applications in diagnosing retinal diseases.
Choroidal Optical Coherence Tomography Angiography (C-OCTA) offers a significant improvement in the analysis of choroidal vessels, a critical component in the ...
National Multiple Sclerosis Society awards $1M to Case Western Reserve University researchers to study new approach to treat the disease
2024-11-04
CLEVELAND—Multiple sclerosis (MS) is a debilitating disease of the brain and spinal cord that impacts millions worldwide.
In MS, the immune system mistakenly attacks the myelin sheath—a protective layer surrounding nerve cells in the nervous system. The loss of myelin, combined with ongoing inflammation, causes dysfunction and death of nerve cells, making the disability worse, such as difficulties with movement, coordination, and sensation.
Treatments now focus on reducing attacks on myelin, but don’t address nerve-cell damage and death.
But with $1 million from the National Multiple ...
Virginia Tech researchers find menthol restrictions may drive smokers to healthier alternatives
2024-11-04
Nationwide, fewer people smoke than did a decade ago, but the proportion who smoke menthol-flavored cigarettes is on the rise.
More than 9 million adults, or about 32 percent of all smokers, use menthol cigarettes, according to the Centers for Disease Control and Prevention. In Virginia, the proportion stands higher, at 38 percent.
A team of researchers including Roberta Freitas-Lemos, assistant professor at Virginia Tech’s Fralin Biomedical Research Institute at VTC, found that if menthol products were unavailable, smokers found replacement therapies such as nicotine gum and lozenges were practical alternatives, potentially improving health outcomes for people who use menthol ...
LAST 30 PRESS RELEASES:
Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk
Promising new drug for people with stubborn high blood pressure
One shot of RSV vaccine effective against hospitalization in older adults for two seasons
Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults
Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis
Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine
High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults
Prevalence, determinants, and time trends of cardiovascular health in the WHO African region
New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers
CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients
Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock
Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes
High Mountain Asia’s shrinking glaciers linked to monsoon changes
All DRII-ed up: How do plants recover after drought?
Research on stigma says to just ‘shake it off’
Scientists track lightning “pollution” in real time using NASA satellite
Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy
Hot days make for icy weather, Philippine study finds
Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology
World's first clinical trial showing lubiprostone aids kidney function
Capturing language change through the genes
Public trust in elections increases with clear facts
Thawing permafrost raised carbon dioxide levels after the last ice age
New DNA test reveals plants’ hidden climate role
Retinitis pigmentosa mouse models reflect pathobiology of human RP59
Cell’s ‘antenna’ could be key to curing diseases
Tiny ocean partnership between algae and bacteria reveals secrets of evolution
Scientists uncover cellular “toolkit” to reprogram immune cells for cancer therapy
Blocking protein control pathway slows rhabdomyosarcoma growth in mice
2026 Hertz Fellowship Application Now Open
[Press-News.org] How the keto diet could one day treat autoimmune disordersA new mouse study from UCSF shows the diet increases anti-inflammatory compounds